ÂÜÀòÂÒÂ×

Jeff Handler, PhD, DABT, MBA is the Vice President of Safety Assessment at Morphic Therapeutic Inc. He brings over 30 years of drug and medical device development experience ranging from pre-clinical and early-stage compounds through support of marketed products in a variety of therapeutic areas. Before joining Morphic he was a consultant for more than 9 years, helping companies that ranged from start-ups to leading pharmaceutical and medical device manufacturers with assistance in toxicology, ADME, project management, CMC and regulatory affairs.

Jeff has also served as Vice President of R&D for Dermik Laboratories/Sanofi Aventis Dermatology, and Vice President of Drug Development for Melior Discovery. He has co-authored more than 60 peer-reviewed publications, abstracts and book chapters, and holds a BS in Biology from Cook College/Rutgers University, a PhD in Pharmacology from the University of North Carolina at Chapel Hill, and an MBA from Villanova University. Jeff is also a Diplomate of the American Board of Toxicology.